
Tina Deignan is Commercial President of Pfizer Oncology, where she leads a team dedicated to accelerating the delivery of breakthrough treatments to people living with cancer. A scientist by training, Tina has spent her career helping translate scientific progress into impact for patients. For Tina, that also means working to ensure innovative therapies reach all people living with ALK-positive cancer who may benefit, with support that reflects the unique needs of each individual patient. #MoreResearchMoreDreams




